Showing results (71-80 of 143) with videos related to
Sort By:
Pageof 15
Vaccine|November 28, 2025
Intraperitoneal administration of cationic liposomes containing a TLR3 agonist recruits type I conventional dendritic cells and primes a local CD8<sup>+</sup> T cell responseSigne Tandrup Schmidt, Julie Zimmermann, Katharina Wørzner, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|May 10, 2019
Effects of cationic adjuvant formulation particle type, fluidity and immunomodulators on delivery and immunogenicity of saRNAAnna K Blakney, Paul F McKay, Dennis Christensen, et al.Innate Immunity|June 3, 2016
Trehalose diester glycolipids are superior to the monoesters in binding to Mincle, activation of macrophages in vitro and adjuvant activity in vivoAlexandra Huber, Rie S Kallerup, Karen S Korsholm, et al.Frontiers in Immunology|August 10, 2019
Site-Specific DC Surface Signatures Influence CD4<sup>+</sup> T Cell Co-stimulation and Lung-HomingDavid Pejoski, Marie Ballester, Floriane Auderset, et al.Frontiers in Immunology|January 24, 2018
Seasonal Influenza Split Vaccines Confer Partial Cross-Protection against Heterologous Influenza Virus in Ferrets When Combined with the CAF01 AdjuvantDennis Christensen, Jan P Christensen, Karen S Korsholm, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|August 31, 2016
The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8(+) T-cell responses: The immunological consequences of the biodistribution profileSigne Tandrup Schmidt, Swapnil Khadke, Karen Smith Korsholm, et al.European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 13, 2008
NIR transmission spectroscopy for rapid determination of lipid and lyoprotector content in liposomal vaccine adjuvant system CAF01Dennis Christensen, Morten Allesø, Ida Rosenkrands, et al.Plos One|June 4, 2009
A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cellsArun T Kamath, Anne-Françoise Rochat, Dennis Christensen, et al.Immunology|February 17, 2007
The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomesKaren Smith Korsholm, Else Marie Agger, Camilla Foged, et al.International Journal of Molecular Sciences|February 15, 2022
A Novel Prophylaxis Strategy Using Liposomal Vaccine Adjuvant CAF09b Protects against Influenza Virus DiseaseJulie Zimmermann, Signe Tandrup Schmidt, Ramona Trebbien, et al.Pageof 15